Global and Japan Bacterial Vaginosis Drug Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 10-Sep-2021
No. of pages: 124
Inquire Before Buying

This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. This report includes metronidazole, clindamycin drug and other drugs.

Global Bacterial Vaginosis Drug key players include Bayer, Pfizer, Sanofi, Piramal, Abbott, etc. Global top five manufacturers hold a share about 20%. North America and Europe is the largest market, both with a share about 30%, followed by China, with a share about 10 percent. In terms of product, OTC is the largest segment, with a share about 70%. And in terms of application, the largest application is Pharmacy, followed by Hospital, etc.

Market Analysis and Insights: Global Bacterial Vaginosis Drug Market

The global Bacterial Vaginosis Drug market size is projected to reach US$ 1095 million by 2027, from US$ 888.1 million in 2020, at a CAGR of 3.0% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bacterial Vaginosis Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bacterial Vaginosis Drug market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bacterial Vaginosis Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bacterial Vaginosis Drug market.

Global Bacterial Vaginosis Drug Scope and Market Size

Bacterial Vaginosis Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bacterial Vaginosis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Rx

- OTC

Segment by Application

- Hospital

- Pharmacy

- Other

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Bayer

- Pfizer

- Sanofi

- Piramal

- Abbott

- Galderma

- Mission

- Alkem

- Xiuzheng

- Teva

- Perrigo

- West-Ward

- HPGC

- Yunnan Baiyao

- Starpharma

- Novel

- Edenvridge

Global and Japan Bacterial Vaginosis Drug Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bacterial Vaginosis Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Rx
1.2.3 OTC
1.3 Market by Application
1.3.1 Global Bacterial Vaginosis Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Bacterial Vaginosis Drug Market Perspective (2016-2027)
2.2 Bacterial Vaginosis Drug Growth Trends by Regions
2.2.1 Bacterial Vaginosis Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bacterial Vaginosis Drug Historic Market Share by Regions (2016-2021)
2.2.3 Bacterial Vaginosis Drug Forecasted Market Size by Regions (2022-2027)
2.3 Bacterial Vaginosis Drug Industry Dynamic
2.3.1 Bacterial Vaginosis Drug Market Trends
2.3.2 Bacterial Vaginosis Drug Market Drivers
2.3.3 Bacterial Vaginosis Drug Market Challenges
2.3.4 Bacterial Vaginosis Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bacterial Vaginosis Drug Players by Revenue
3.1.1 Global Top Bacterial Vaginosis Drug Players by Revenue (2016-2021)
3.1.2 Global Bacterial Vaginosis Drug Revenue Market Share by Players (2016-2021)
3.2 Global Bacterial Vaginosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bacterial Vaginosis Drug Revenue
3.4 Global Bacterial Vaginosis Drug Market Concentration Ratio
3.4.1 Global Bacterial Vaginosis Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bacterial Vaginosis Drug Revenue in 2020
3.5 Bacterial Vaginosis Drug Key Players Head office and Area Served
3.6 Key Players Bacterial Vaginosis Drug Product Solution and Service
3.7 Date of Enter into Bacterial Vaginosis Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bacterial Vaginosis Drug Breakdown Data by Type
4.1 Global Bacterial Vaginosis Drug Historic Market Size by Type (2016-2021)
4.2 Global Bacterial Vaginosis Drug Forecasted Market Size by Type (2022-2027)
5 Bacterial Vaginosis Drug Breakdown Data by Application
5.1 Global Bacterial Vaginosis Drug Historic Market Size by Application (2016-2021)
5.2 Global Bacterial Vaginosis Drug Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Bacterial Vaginosis Drug Market Size (2016-2027)
6.2 North America Bacterial Vaginosis Drug Market Size by Type
6.2.1 North America Bacterial Vaginosis Drug Market Size by Type (2016-2021)
6.2.2 North America Bacterial Vaginosis Drug Market Size by Type (2022-2027)
6.2.3 North America Bacterial Vaginosis Drug Market Size by Type (2016-2027)
6.3 North America Bacterial Vaginosis Drug Market Size by Application
6.3.1 North America Bacterial Vaginosis Drug Market Size by Application (2016-2021)
6.3.2 North America Bacterial Vaginosis Drug Market Size by Application (2022-2027)
6.3.3 North America Bacterial Vaginosis Drug Market Size by Application (2016-2027)
6.4 North America Bacterial Vaginosis Drug Market Size by Country
6.4.1 North America Bacterial Vaginosis Drug Market Size by Country (2016-2021)
6.4.2 North America Bacterial Vaginosis Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Bacterial Vaginosis Drug Market Size (2016-2027)
7.2 Europe Bacterial Vaginosis Drug Market Size by Type
7.2.1 Europe Bacterial Vaginosis Drug Market Size by Type (2016-2021)
7.2.2 Europe Bacterial Vaginosis Drug Market Size by Type (2022-2027)
7.2.3 Europe Bacterial Vaginosis Drug Market Size by Type (2016-2027)
7.3 Europe Bacterial Vaginosis Drug Market Size by Application
7.3.1 Europe Bacterial Vaginosis Drug Market Size by Application (2016-2021)
7.3.2 Europe Bacterial Vaginosis Drug Market Size by Application (2022-2027)
7.3.3 Europe Bacterial Vaginosis Drug Market Size by Application (2016-2027)
7.4 Europe Bacterial Vaginosis Drug Market Size by Country
7.4.1 Europe Bacterial Vaginosis Drug Market Size by Country (2016-2021)
7.4.2 Europe Bacterial Vaginosis Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Bacterial Vaginosis Drug Market Size (2016-2027)
8.2 Asia-Pacific Bacterial Vaginosis Drug Market Size by Type
8.2.1 Asia-Pacific Bacterial Vaginosis Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bacterial Vaginosis Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bacterial Vaginosis Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Bacterial Vaginosis Drug Market Size by Application
8.3.1 Asia-Pacific Bacterial Vaginosis Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bacterial Vaginosis Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bacterial Vaginosis Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Bacterial Vaginosis Drug Market Size by Region
8.4.1 Asia-Pacific Bacterial Vaginosis Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bacterial Vaginosis Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Bacterial Vaginosis Drug Market Size (2016-2027)
9.2 Latin America Bacterial Vaginosis Drug Market Size by Type
9.2.1 Latin America Bacterial Vaginosis Drug Market Size by Type (2016-2021)
9.2.2 Latin America Bacterial Vaginosis Drug Market Size by Type (2022-2027)
9.2.3 Latin America Bacterial Vaginosis Drug Market Size by Type (2016-2027)
9.3 Latin America Bacterial Vaginosis Drug Market Size by Application
9.3.1 Latin America Bacterial Vaginosis Drug Market Size by Application (2016-2021)
9.3.2 Latin America Bacterial Vaginosis Drug Market Size by Application (2022-2027)
9.3.3 Latin America Bacterial Vaginosis Drug Market Size by Application (2016-2027)
9.4 Latin America Bacterial Vaginosis Drug Market Size by Country
9.4.1 Latin America Bacterial Vaginosis Drug Market Size by Country (2016-2021)
9.4.2 Latin America Bacterial Vaginosis Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bacterial Vaginosis Drug Market Size (2016-2027)
10.2 Middle East & Africa Bacterial Vaginosis Drug Market Size by Type
10.2.1 Middle East & Africa Bacterial Vaginosis Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bacterial Vaginosis Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bacterial Vaginosis Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Bacterial Vaginosis Drug Market Size by Application
10.3.1 Middle East & Africa Bacterial Vaginosis Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bacterial Vaginosis Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bacterial Vaginosis Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Bacterial Vaginosis Drug Market Size by Country
10.4.1 Middle East & Africa Bacterial Vaginosis Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bacterial Vaginosis Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Bacterial Vaginosis Drug Introduction
11.1.4 Bayer Revenue in Bacterial Vaginosis Drug Business (2016-2021)
11.1.5 Bayer Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Bacterial Vaginosis Drug Introduction
11.2.4 Pfizer Revenue in Bacterial Vaginosis Drug Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Bacterial Vaginosis Drug Introduction
11.3.4 Sanofi Revenue in Bacterial Vaginosis Drug Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 Piramal
11.4.1 Piramal Company Details
11.4.2 Piramal Business Overview
11.4.3 Piramal Bacterial Vaginosis Drug Introduction
11.4.4 Piramal Revenue in Bacterial Vaginosis Drug Business (2016-2021)
11.4.5 Piramal Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Bacterial Vaginosis Drug Introduction
11.5.4 Abbott Revenue in Bacterial Vaginosis Drug Business (2016-2021)
11.5.5 Abbott Recent Development
11.6 Galderma
11.6.1 Galderma Company Details
11.6.2 Galderma Business Overview
11.6.3 Galderma Bacterial Vaginosis Drug Introduction
11.6.4 Galderma Revenue in Bacterial Vaginosis Drug Business (2016-2021)
11.6.5 Galderma Recent Development
11.7 Mission
11.7.1 Mission Company Details
11.7.2 Mission Business Overview
11.7.3 Mission Bacterial Vaginosis Drug Introduction
11.7.4 Mission Revenue in Bacterial Vaginosis Drug Business (2016-2021)
11.7.5 Mission Recent Development
11.8 Alkem
11.8.1 Alkem Company Details
11.8.2 Alkem Business Overview
11.8.3 Alkem Bacterial Vaginosis Drug Introduction
11.8.4 Alkem Revenue in Bacterial Vaginosis Drug Business (2016-2021)
11.8.5 Alkem Recent Development
11.9 Xiuzheng
11.9.1 Xiuzheng Company Details
11.9.2 Xiuzheng Business Overview
11.9.3 Xiuzheng Bacterial Vaginosis Drug Introduction
11.9.4 Xiuzheng Revenue in Bacterial Vaginosis Drug Business (2016-2021)
11.9.5 Xiuzheng Recent Development
11.10 Teva
11.10.1 Teva Company Details
11.10.2 Teva Business Overview
11.10.3 Teva Bacterial Vaginosis Drug Introduction
11.10.4 Teva Revenue in Bacterial Vaginosis Drug Business (2016-2021)
11.10.5 Teva Recent Development
11.11 Perrigo
11.11.1 Perrigo Company Details
11.11.2 Perrigo Business Overview
11.11.3 Perrigo Bacterial Vaginosis Drug Introduction
11.11.4 Perrigo Revenue in Bacterial Vaginosis Drug Business (2016-2021)
11.11.5 Perrigo Recent Development
11.12 West-Ward
11.12.1 West-Ward Company Details
11.12.2 West-Ward Business Overview
11.12.3 West-Ward Bacterial Vaginosis Drug Introduction
11.12.4 West-Ward Revenue in Bacterial Vaginosis Drug Business (2016-2021)
11.12.5 West-Ward Recent Development
11.13 HPGC
11.13.1 HPGC Company Details
11.13.2 HPGC Business Overview
11.13.3 HPGC Bacterial Vaginosis Drug Introduction
11.13.4 HPGC Revenue in Bacterial Vaginosis Drug Business (2016-2021)
11.13.5 HPGC Recent Development
11.14 Yunnan Baiyao
11.14.1 Yunnan Baiyao Company Details
11.14.2 Yunnan Baiyao Business Overview
11.14.3 Yunnan Baiyao Bacterial Vaginosis Drug Introduction
11.14.4 Yunnan Baiyao Revenue in Bacterial Vaginosis Drug Business (2016-2021)
11.14.5 Yunnan Baiyao Recent Development
11.15 Starpharma
11.15.1 Starpharma Company Details
11.15.2 Starpharma Business Overview
11.15.3 Starpharma Bacterial Vaginosis Drug Introduction
11.15.4 Starpharma Revenue in Bacterial Vaginosis Drug Business (2016-2021)
11.15.5 Starpharma Recent Development
11.16 Novel
11.16.1 Novel Company Details
11.16.2 Novel Business Overview
11.16.3 Novel Bacterial Vaginosis Drug Introduction
11.16.4 Novel Revenue in Bacterial Vaginosis Drug Business (2016-2021)
11.16.5 Novel Recent Development
11.17 Edenvridge
11.17.1 Edenvridge Company Details
11.17.2 Edenvridge Business Overview
11.17.3 Edenvridge Bacterial Vaginosis Drug Introduction
11.17.4 Edenvridge Revenue in Bacterial Vaginosis Drug Business (2016-2021)
11.17.5 Edenvridge Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Bacterial Vaginosis Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Rx
Table 3. Key Players of OTC
Table 4. Global Bacterial Vaginosis Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Bacterial Vaginosis Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Bacterial Vaginosis Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Bacterial Vaginosis Drug Market Share by Regions (2016-2021)
Table 8. Global Bacterial Vaginosis Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Bacterial Vaginosis Drug Market Share by Regions (2022-2027)
Table 10. Bacterial Vaginosis Drug Market Trends
Table 11. Bacterial Vaginosis Drug Market Drivers
Table 12. Bacterial Vaginosis Drug Market Challenges
Table 13. Bacterial Vaginosis Drug Market Restraints
Table 14. Global Bacterial Vaginosis Drug Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Bacterial Vaginosis Drug Market Share by Players (2016-2021)
Table 16. Global Top Bacterial Vaginosis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bacterial Vaginosis Drug as of 2020)
Table 17. Ranking of Global Top Bacterial Vaginosis Drug Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Bacterial Vaginosis Drug Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Bacterial Vaginosis Drug Product Solution and Service
Table 21. Date of Enter into Bacterial Vaginosis Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Bacterial Vaginosis Drug Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Bacterial Vaginosis Drug Revenue Market Share by Type (2016-2021)
Table 25. Global Bacterial Vaginosis Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Bacterial Vaginosis Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Bacterial Vaginosis Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Bacterial Vaginosis Drug Revenue Market Share by Application (2016-2021)
Table 29. Global Bacterial Vaginosis Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Bacterial Vaginosis Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Bacterial Vaginosis Drug Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Bacterial Vaginosis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Bacterial Vaginosis Drug Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Bacterial Vaginosis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Bacterial Vaginosis Drug Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Bacterial Vaginosis Drug Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Bacterial Vaginosis Drug Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Bacterial Vaginosis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Bacterial Vaginosis Drug Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Bacterial Vaginosis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Bacterial Vaginosis Drug Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Bacterial Vaginosis Drug Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Bacterial Vaginosis Drug Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Bacterial Vaginosis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Bacterial Vaginosis Drug Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Bacterial Vaginosis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Bacterial Vaginosis Drug Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Bacterial Vaginosis Drug Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Bacterial Vaginosis Drug Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Bacterial Vaginosis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Bacterial Vaginosis Drug Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Bacterial Vaginosis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Bacterial Vaginosis Drug Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Bacterial Vaginosis Drug Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Bacterial Vaginosis Drug Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Bacterial Vaginosis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Bacterial Vaginosis Drug Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Bacterial Vaginosis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Bacterial Vaginosis Drug Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Bacterial Vaginosis Drug Market Size by Country (2022-2027) & (US$ Million)
Table 61. Bayer Company Details
Table 62. Bayer Business Overview
Table 63. Bayer Bacterial Vaginosis Drug Product
Table 64. Bayer Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million)
Table 65. Bayer Recent Development
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Bacterial Vaginosis Drug Product
Table 69. Pfizer Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Sanofi Company Details
Table 72. Sanofi Business Overview
Table 73. Sanofi Bacterial Vaginosis Drug Product
Table 74. Sanofi Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million)
Table 75. Sanofi Recent Development
Table 76. Piramal Company Details
Table 77. Piramal Business Overview
Table 78. Piramal Bacterial Vaginosis Drug Product
Table 79. Piramal Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million)
Table 80. Piramal Recent Development
Table 81. Abbott Company Details
Table 82. Abbott Business Overview
Table 83. Abbott Bacterial Vaginosis Drug Product
Table 84. Abbott Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million)
Table 85. Abbott Recent Development
Table 86. Galderma Company Details
Table 87. Galderma Business Overview
Table 88. Galderma Bacterial Vaginosis Drug Product
Table 89. Galderma Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million)
Table 90. Galderma Recent Development
Table 91. Mission Company Details
Table 92. Mission Business Overview
Table 93. Mission Bacterial Vaginosis Drug Product
Table 94. Mission Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million)
Table 95. Mission Recent Development
Table 96. Alkem Company Details
Table 97. Alkem Business Overview
Table 98. Alkem Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million)
Table 99. Alkem Recent Development
Table 100. Xiuzheng Company Details
Table 101. Xiuzheng Business Overview
Table 102. Xiuzheng Bacterial Vaginosis Drug Product
Table 103. Xiuzheng Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million)
Table 104. Xiuzheng Recent Development
Table 105. Teva Company Details
Table 106. Teva Business Overview
Table 107. Teva Bacterial Vaginosis Drug Product
Table 108. Teva Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million)
Table 109. Teva Recent Development
Table 110. Perrigo Company Details
Table 111. Perrigo Business Overview
Table 112. Perrigo Bacterial Vaginosis Drug Product
Table 113. Perrigo Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million)
Table 114. Perrigo Recent Development
Table 115. West-Ward Company Details
Table 116. West-Ward Business Overview
Table 117. West-Ward Bacterial Vaginosis Drug Product
Table 118. West-Ward Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million)
Table 119. West-Ward Recent Development
Table 120. HPGC Company Details
Table 121. HPGC Business Overview
Table 122. HPGC Bacterial Vaginosis Drug Product
Table 123. HPGC Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million)
Table 124. HPGC Recent Development
Table 125. Yunnan Baiyao Company Details
Table 126. Yunnan Baiyao Business Overview
Table 127. Yunnan Baiyao Bacterial Vaginosis Drug Product
Table 128. Yunnan Baiyao Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million)
Table 129. Yunnan Baiyao Recent Development
Table 130. Starpharma Company Details
Table 131. Starpharma Business Overview
Table 132. Starpharma Bacterial Vaginosis Drug Product
Table 133. Starpharma Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million)
Table 134. Starpharma Recent Development
Table 135. Novel Company Details
Table 136. Novel Business Overview
Table 137. Novel Bacterial Vaginosis Drug Product
Table 138. Novel Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million)
Table 139. Novel Recent Development
Table 140. Edenvridge Company Details
Table 141. Edenvridge Business Overview
Table 142. Edenvridge Bacterial Vaginosis Drug Product
Table 143. Edenvridge Revenue in Bacterial Vaginosis Drug Business (2016-2021) & (US$ Million)
Table 144. Edenvridge Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bacterial Vaginosis Drug Market Share by Type: 2020 VS 2027
Figure 2. Rx Features
Figure 3. OTC Features
Figure 4. Global Bacterial Vaginosis Drug Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Pharmacy Case Studies
Figure 7. Other Case Studies
Figure 8. Bacterial Vaginosis Drug Report Years Considered
Figure 9. Global Bacterial Vaginosis Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Bacterial Vaginosis Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Bacterial Vaginosis Drug Market Share by Regions: 2020 VS 2027
Figure 12. Global Bacterial Vaginosis Drug Market Share by Regions (2022-2027)
Figure 13. Global Bacterial Vaginosis Drug Market Share by Players in 2020
Figure 14. Global Top Bacterial Vaginosis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bacterial Vaginosis Drug as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Bacterial Vaginosis Drug Revenue in 2020
Figure 16. Global Bacterial Vaginosis Drug Revenue Market Share by Type (2016-2021)
Figure 17. Global Bacterial Vaginosis Drug Revenue Market Share by Type (2022-2027)
Figure 18. North America Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Bacterial Vaginosis Drug Market Share by Type (2016-2027)
Figure 20. North America Bacterial Vaginosis Drug Market Share by Application (2016-2027)
Figure 21. North America Bacterial Vaginosis Drug Market Share by Country (2016-2027)
Figure 22. United States Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Bacterial Vaginosis Drug Market Share by Type (2016-2027)
Figure 26. Europe Bacterial Vaginosis Drug Market Share by Application (2016-2027)
Figure 27. Europe Bacterial Vaginosis Drug Market Share by Country (2016-2027)
Figure 28. Germany Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Bacterial Vaginosis Drug Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Bacterial Vaginosis Drug Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Bacterial Vaginosis Drug Market Share by Region (2016-2027)
Figure 38. China Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Bacterial Vaginosis Drug Market Share by Type (2016-2027)
Figure 46. Latin America Bacterial Vaginosis Drug Market Share by Application (2016-2027)
Figure 47. Latin America Bacterial Vaginosis Drug Market Share by Country (2016-2027)
Figure 48. Mexico Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Bacterial Vaginosis Drug Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Bacterial Vaginosis Drug Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Bacterial Vaginosis Drug Market Share by Country (2016-2027)
Figure 54. Turkey Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Bacterial Vaginosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Bayer Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021)
Figure 58. Pfizer Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021)
Figure 59. Sanofi Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021)
Figure 60. Piramal Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021)
Figure 61. Abbott Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021)
Figure 62. Galderma Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021)
Figure 63. Mission Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021)
Figure 64. Alkem Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021)
Figure 65. Xiuzheng Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021)
Figure 66. Teva Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021)
Figure 67. Perrigo Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021)
Figure 68. West-Ward Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021)
Figure 69. HPGC Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021)
Figure 70. Yunnan Baiyao Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021)
Figure 71. Starpharma Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021)
Figure 72. Novel Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021)
Figure 73. Edenvridge Revenue Growth Rate in Bacterial Vaginosis Drug Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
  • United States Contraceptives Market Report & Forecast 2021-2027
    Published: 13-Sep-2021        Price: US 3400 Onwards        Pages: 93
    United States Contraceptives Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (MT) United States Contraceptives Market Segment Percentages, By Type, 2020 (%) - Prolonged Contraception - Short-term Contraception - Emergency Contraception United States Contraceptives Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (MT) United States Contraceptives Market Segment Percentages, By Application, 2020 (%) - Hospital Pharmacies......
  • Global and Japan Bacterial Vaginosis Drug Market Size, Status and Forecast 2021-2027
    Published: 10-Sep-2021        Price: US 3900 Onwards        Pages: 124
    This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. This report includes metronidazole, clindamycin drug and other drugs. Global Bacterial Vaginosis Drug key players include Bayer, Pfizer, Sanofi, Piramal, Abbott, etc. Global top five manufacturers hold a share about 20%. North America a......
  • Global and United States Contraceptives Market Insights, Forecast to 2027
    Published: 10-Sep-2021        Price: US 3900 Onwards        Pages: 148
    Contraceptives are a kind of medicine used to prevent unwanted pregnancy. It consists of one or more synthetic female sex hormones. These sex hormones prevent pregnancy by blocking the normal process of ovulation. Europe is the largest Contraceptives market with about 44% market share. North America is follower, accounting for about 37% market share. The key players are Bayer AG, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Actavis, Inc., Johnson & Johnson, Ged......
  • United States Drugs for Vulvovaginal Candidiasis Market Report & Forecast 2021-2027
    Published: 10-Sep-2021        Price: US 3400 Onwards        Pages: 90
    United States Drugs for Vulvovaginal Candidiasis Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units) United States Drugs for Vulvovaginal Candidiasis Market Segment Percentages, By Type, 2020 (%) - Cream - Pessary - Other United States Drugs for Vulvovaginal Candidiasis Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units) United States Drugs for Vulvovaginal Candidiasis Market Segment Percentages, By Application, 2020 ......
  • United States Bacterial Vaginosis Drug Market Report & Forecast 2021-2027
    Published: 08-Sep-2021        Price: US 3400 Onwards        Pages: 109
    United States Bacterial Vaginosis Drug Market, By Type, 2016-2021, 2022-2027 ($ Millions) United States Bacterial Vaginosis Drug Market Segment Percentages, By Type, 2020 (%) - Rx - OTC United States Bacterial Vaginosis Drug Market, By Application, 2016-2021, 2022-2027 ($ Millions) United States Bacterial Vaginosis Drug Market Segment Percentages, By Application, 2020 (%) - Hospital - Pharmacy - Other Competitor Analy......
  • 2021-2030 Report on Global Bacterial Vaginosis Drug Market by Player, Region, Type, Application and Sales Channel
    Published: 07-Sep-2021        Price: US 2500 Onwards        Pages: 117
    This report studies the Bacterial Vaginosis Drug market, covering market size for segment by type (Rx Drugs, OTC Drugs, etc.), by application (Hospitals & Clinics, Retail Pharmacy, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Bayer, Pfizer, Sanofi, Piramal, Abbott, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Bacterial Vaginosis......
  • Global and United States Oral Contraceptive Market Insights, Forecast to 2027
    Published: 31-Aug-2021        Price: US 3900 Onwards        Pages: 139
    Oral Contraceptive market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Oral Contraceptive market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For United States market, this report focuses on the Oral Contra......
  • Global Bacterial Vaginosis Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 27-Aug-2021        Price: US 3480 Onwards        Pages: 138
    The Bacterial Vaginosis Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our lates......
  • Global Contraceptives Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 26-Aug-2021        Price: US 3480 Onwards        Pages: 107
    The Contraceptives market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our latest research......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs